No Data
No Data
Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress
CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21
Buy Rating Affirmed for Delcath Systems Amidst Strong Hepzato Launch and Promising Future Prospects
Express News | Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Growth Investors: Industry Analysts Just Upgraded Their Delcath Systems, Inc. (NASDAQ:DCTH) Revenue Forecasts By 13%
Delcath Systems Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags